Bioavailability is the percentage of a drug that actually reaches your bloodstream and becomes available to work in your body. When you swallow a pill, not all of it makes it into circulation. Some gets broken down in your gut, some gets filtered out by your liver, and some never dissolves well enough to be absorbed in the first place. Bioavailability captures all of those losses in a single number.
Why Intravenous Is the Gold Standard
A drug injected directly into a vein has 100% bioavailability by definition, because nothing stands between it and your bloodstream. Every other route of administration is measured against that benchmark. If a drug taken by mouth has a bioavailability of 50%, that means only half the dose you swallowed ends up circulating through your body compared to what an IV injection would deliver.
Researchers calculate this by measuring drug levels in the blood over time after a dose, then plotting those levels on a graph. The total area under that curve (called AUC) represents overall drug exposure. To find bioavailability, they compare the AUC from an oral dose to the AUC from an IV dose of the same drug. A ratio of 1 means full absorption; anything less tells you how much was lost along the way.
How First-Pass Metabolism Reduces Absorption
The biggest reason oral drugs lose bioavailability is something called first-pass metabolism. When you swallow a medication, it dissolves in your stomach and small intestine, then gets absorbed into blood vessels that feed directly into the liver through the portal vein. The liver is essentially a filtration plant packed with enzymes whose job is to break down foreign chemicals. Before a single molecule of drug reaches the rest of your body, the liver has already metabolized a portion of it.
The liver isn’t the only barrier. The lining of your intestine also contains high concentrations of the same breakdown enzymes, particularly two called CYP3A4 and CYP2D6. These enzymes begin dismantling certain drugs before they even cross the gut wall into the bloodstream. For some medications, the combined effect of gut and liver metabolism destroys the majority of each dose. That’s why certain drugs require much higher oral doses than their IV equivalents, or why some drugs can’t be given by mouth at all.
First-pass metabolism is enzyme-driven, which means it can become saturated. At very high doses, the enzymes can’t keep up, and a larger fraction of drug slips through. This is one reason why doubling a dose doesn’t always double the drug’s effect in a predictable way.
Physical Properties That Determine Absorption
Before a drug can even encounter the liver, it has to dissolve in your gut and cross cell membranes to enter the bloodstream. Whether it can do that depends on its chemical makeup. Lipophilicity, a measure of how well a molecule dissolves in fats versus water, is one of the most important factors. Drugs need some fat-solubility to pass through cell membranes, which are made of fatty molecules. But too much lipophilicity creates problems: the drug accumulates in tissues, binds heavily to blood proteins, and gets rapidly metabolized. Studies show that the best oral bioavailability tends to fall in a moderate range of fat-solubility, with log P values (the standard measure) between 0 and 3.
Pharmaceutical scientists use a set of guidelines called Lipinski’s Rule of Five to predict whether a new compound will absorb well. A drug is more likely to have good oral bioavailability if its molecular weight is under 500, it has no more than 5 hydrogen bond donors and 10 hydrogen bond acceptors, and its fat-solubility stays below a certain threshold. These aren’t hard rules, but drugs that violate multiple criteria tend to have absorption problems.
How Food Changes Drug Absorption
What you eat before or after taking a medication can dramatically alter how much of it reaches your bloodstream. High-fat and high-protein meals slow down stomach emptying by triggering hormones that reduce the stomach’s contractions. This delays the drug’s arrival at the small intestine, where most absorption happens. For some drugs, that delay is clinically meaningful.
Fat-soluble drugs often absorb much better with food. The antifungal medication posaconazole, for example, shows up to 400% higher blood levels when its oral suspension is taken with a high-fat meal compared to an empty stomach. Cannabidiol is an even more extreme case: high-fat meals can increase its peak blood concentration by a factor of 17.4, because dietary fat enhances the drug’s solubility in the gut, reduces the liver’s first-pass breakdown, and promotes an alternative absorption pathway through the lymphatic system.
Food also changes the acidity of your stomach. Eating temporarily raises stomach pH by neutralizing some of the acid. This matters for drugs that need an acidic environment to dissolve properly. Several medications, including certain antifungals and cancer drugs, show impaired and unpredictable absorption when stomach acid is low. Dairy products are particularly effective at raising stomach pH, which is one reason some medications carry instructions to avoid milk.
Why Bioavailability Matters for Dosing
Bioavailability directly determines how much of a drug you need to take to achieve a therapeutic effect. A drug with low bioavailability requires a higher oral dose to compensate for what’s lost during absorption and first-pass metabolism. A drug with highly variable bioavailability, meaning the amount absorbed changes unpredictably from dose to dose or person to person, poses a different kind of problem.
When a drug has a narrow therapeutic window (the gap between an effective dose and a toxic one is small), even modest swings in bioavailability can push patients into either ineffective or dangerous territory. The FDA notes that drugs where blood-level measurements are critical for safe use may need tighter standards for how consistently they’re absorbed. For these medications, doctors sometimes use therapeutic drug monitoring, checking blood levels at intervals to make sure the drug stays in the right range.
Bioavailability also plays a central role in generic drug approval. A generic medication must demonstrate that it delivers the same rate and extent of absorption as the brand-name version. If it doesn’t, the manufacturer has to prove that the differences won’t meaningfully affect how well the drug works or how safe it is. This is why you’ll sometimes hear the term “bioequivalence” in the context of generics. Two products are bioequivalent when their AUC values and peak blood concentrations fall within an acceptable range of each other.
Bioavailability Across Different Routes
The route you use to take a medication is one of the biggest levers on bioavailability. Oral administration is the most common but generally produces the lowest and most variable bioavailability, because the drug must survive the digestive tract and liver. Sublingual tablets, dissolved under the tongue, bypass the gut and liver by absorbing directly into blood vessels in the mouth. This is why nitroglycerin for chest pain is placed under the tongue rather than swallowed.
Transdermal patches deliver drugs through the skin at a slow, steady rate, avoiding first-pass metabolism entirely. But the skin is a formidable barrier, so only drugs with the right molecular size and fat-solubility work well this way. Rectal administration partially avoids first-pass metabolism because veins in the lower rectum drain into the general circulation rather than the portal vein, though absorption can be inconsistent. Inhaled drugs reach the lungs, which have a massive surface area and rich blood supply, allowing rapid absorption for medications targeting respiratory conditions or requiring fast systemic effects.
Each route involves trade-offs between convenience, speed of onset, consistency of absorption, and the fraction of drug that ultimately reaches circulation. The choice of route shapes not just how much drug gets into your body, but how quickly it peaks, how long it lasts, and how predictably it behaves from one dose to the next.